Total cholesterol and the risk of parkinson's disease: A review for some new findings

Parkinson's Disease

Volumn , Issue , 2010, Pages

  Hu, Gang ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UBIDECARENONE;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; DEMENTIA; DISEASE ASSOCIATION; FAT INTAKE; HISTORY; HUMAN; HYPERCHOLESTEROLEMIA; OBESITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW;

EID: 77955941572     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2010/836962     Document Type: Review

References (30)

1. Lang A. E., Lozano A. M., Parkinsons disease. First of two parts The New England Journal of Medicine 1998 339 15 1044 1053
2. Tanner C. M., Ottman R., Goldman S. M., Parkinson disease in twins: an etiologic study Journal of the American Medical Association 1999 281 4 341 346
3. Sveinbjornsdottir S., Hicks A. A., Jonsson T., Familial aggregation of Parkinsons disease in Iceland The New England Journal of Medicine 2000 343 24 1765 1770
4. Lewington S., Whitlock G., Clarke R., Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths The Lancet 2007 370 1829 1839
5. Notkola I. L., Sulkava R., Pekkanen J., Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimers disease Neuroepidemiology 1998 17 1 14 20
6. Kivipelto M., Helkala E. L., Laakso M. P., Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease Annals of Internal Medicine 2002 137 3 149 155
7. Suh I., Jee S. H., Kim H. C., Nam C. M., Kim I. S., Appel L. J., Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study The Lancet 2001 357 9260 922 925
8. Teunissen C. E., Lutjohann D., Von Bergmann K., Combination of serum markers related to several mechanisms in Alzheimers disease Neurobiology of Aging 2003 24 7 893 902
9. Sohmiya M., Tanaka M., Tak N. W., Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinsons disease Journal of the Neurological Sciences 2004 223 2 161 166
10. Scigliano G., Musicco M., Soliveri P., Piccolo I., Ronchetti G., Girotti F., Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study Stroke 2006 37 5 1184 1188
11. Huang X., Chen H., Miller W. C., Lower low-density lipoprotein cholesterol levels are associated with Parkinsons disease Movement Disorders 2007 22 3 377 381
12. Grandinetti A., Morens D. M., Reed D., Maceachern D., Prospective study of cigarette smoking and the risk of developing idiopathic Parkinsons disease American Journal of Epidemiology 1994 139 12 1129 1138
13. Huang X., Abbott R. D., Petrovitch H., Mailman R. B., Ross G. W., Low LDL cholesterol and increased risk of Parkinsons disease: prospective results from Honolulu-Asia Aging Study Movement Disorders 2008 23 7 1013 1018
14. De Lau L. M., Koudstaal P. J., Hofman A., Breteler M. M., Serum cholesterol levels and the risk of Parkinsons disease American Journal of Epidemiology 2006 164 10 998 1002
15. Simon K. C., Chen H., Schwarzschild M., Ascherio A., Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease Neurology 2007 69 17 1688 1695
16. Hu G., Antikainen R., Jousilahti P., Kivipelto M., Tuomilehto J., Total cholesterol and the risk of Parkinson disease Neurology 2008 70 21 1972 1979
17. Solomon A., Kareholt I., Ngandu T., Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study Neurology 2007 68 10 751 756
18. Reiss A. B., Siller K. A., Rahman M. M., Chan E. S., Ghiso J., De Leon M. J., Cholesterol in neurologic disorders of the elderly: stroke and Alzheimers disease Neurobiology of Aging 2004 25 8 977 989
19. Bar-On P., Rockenstein E., Adame A., Ho G., Hashimoto M., Masliah E., Effects of the cholesterol-lowering compound methyl- -cyclodextrin in models of -synucleinopathy Journal of Neurochemistry 2006 98 4 1032 1045
20. Barcelo-Coblijn G., Golovko M. Y., Weinhofer I., Berger J., Murphy E. J., Brain neutral lipids mass is increased in -synuclein gene-ablated mice Journal of Neurochemistry 2007 101 1 132 141
21. Jick H., Zornberg G. L., Jick S. S., Seshadri S., Drachman D. A., Statins and the risk of dementia The Lancet 2000 356 9242 1627 1631
22. Hu G., Jousilahti P., Nissinen A., Antikainen R., Kivipelto M., Tuomilehto J., Body mass index and the risk of Parkinson disease Neurology 2006 67 11 1955 1959
23. Abbott R. D., Ross G. W., White L. R., Midlife adiposity and the future risk of Parkinsons disease Neurology 2002 59 7 1051 1057
24. Chen H., Zhang S. M., Schwarzschild M. A., Hernan M. A., Ascherio A., Physical activity and the risk of Parkinson disease Neurology 2005 64 4 664 669
25. Hu G., Jousilahti P., Bidel S., Antikainen R., Tuomilehto J., Type 2 diabetes and the risk of Parkinsons disease Diabetes Care 2007 30 4 842 847
26. Hu G., Bidel S., Jousilahti P., Antikainen R., Tuomilehto J., Coffee and tea consumption and the risk of Parkinsons disease Movement Disorders 2007 22 15 2242 2248
27. Hernan M. A., Takkouche B., Caamano-Isorna F., Gestal-Otero J. J., A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinsons disease Annals of Neurology 2002 52 3 276 284
28. Logroscino G., Marder K., Cote L., Tang M. X., Shea S., Mayeux R., Dietary lipids and antioxidants in Parkinsons disease: a population-based, case-control study Annals of Neurology 1996 39 1 89 94
29. Johnson C. C., Gorell J. M., Rybicki B. A., Sanders K., Peterson E. L., Adult nutrient intake as a risk factor for Parkinsons disease International Journal of Epidemiology 1999 28 6 1102 1109
30. Chen H., Zhang S. M., Hernan M. A., Willett W. C., Ascherio A., Dietary intakes of fat and risk of Parkinsons disease American Journal of Epidemiology 2003 157 11 1007 1014